- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06350383
Adapting a Low-cost Intimate Partner Violence and Mental Health Response Intervention
Adapting a Low-cost Intimate Partner Violence (IPV) and Mental Health Response Intervention for Women in Informal Settlements in Kenya
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Women experiencing IPV (n=260) will be recruited from the outpatient walk-in departments at Kianda 42 Clinic in Kibera informal settlement (n=130) and Upendo Clinic in Mathare informal settlement (n=130). Consenting patients will be screened for recent experiences of IPV (past 3 months) by nurses or staff using an adapted version of the World Health Organization (WHO) IPV Brief Self-screener (IPV-BSS) and asked several mental health and functioning questions.
Informational scripts about the study will be shared and posted at the two clinics and also shared by community health volunteers (CHVs) with clinic patients during routine household visits. Every CHV who is attached to a clinic is responsible for doing routine visits with clinic patients in up to 100 households each month in the informal settlement in which the clinic is located. The purpose of these routine household visits is to check-in on patients, let households know about new or relevant clinic programs, and carry out relevant health-related trainings (e.g., how to treat water during a cholera outbreak or how to practice proper hygiene during COVID). The informational script will let patients in the clinics and broader community know that, if they are interested in the program, they can come to the clinic to be screened for eligibility.
Eligibility/IPV screens will be collected by trained non-specialist in-take staff in a private in-take room at the Kianda 42 Clinic in Kibera and Upendo in Mathare. Screening is anonymous. No identifying information will be collected as part of the screen. Answers to the screening questions will be recorded on digitally on study tablets. Verbal consent for eligibility screens will be collected. In-take staff will note on the informed consent document that the participant verbally consented to the screening, and sign their own names to attest to participants' consent.
If women screen positive for IPV in the past three months and meet the rest of the eligibility criteria, they will be asked if they are interested in participating in the feasibility trial. If they express interest, they will be referred to a trained CHV who will take them through the a digital Informed Consent Process for the feasibility trial.
Consenting participants will be guided through a baseline assessment by a CHV and then randomized to either the combined WINGS+PM+ (n=130; 65 at Kianda 42 and 65 at Upendo) or the psychological-only (PM+) arm (n=130; 65 at Kianda 42 and 65 at Upendo). Block randomization with random block sizes will be used to "force" a balance between study arms with respect to the number of women per arm per clinic.
WINGS+PM+ and PM+-only sessions will be delivered by trained CHVs at Kianda 42 and Upendo. WINGS+PM+ is a safety, harm reduction, and brief psychological intervention combined and adapted by community members from informal settlements in Kenya (IPV survivors, health clinic staff, and CHVs) from two evidence-based interventions: Wings of Hope (WINGS) and Problem Management Plus (PM+). This intervention was designed to be facilitated by non-specialists (e.g., CHVs). It involves seven 90-minute weekly sessions focused on exploring types and mechanisms of IPV (e.g., the role of household economics in IPV); building motivation to address IPV; safety planning and revision; enhancing social support to address IPV; goal setting and revision; identifying IPV-related services and needs; linkage and referral to services; self-care planning; learning and practicing a stress management technique; identifying, defining, and managing problems through goal setting and review; increasing engagement in positive activities; strengthening social supports; and developing plans to stay healthy and well beyond the intervention. PM+: is a brief psychological intervention also designed to be facilitated by non-specialists (e.g. CHVs) and focused on problem management and evidence-based behavioral strategies to enhance one's capacity to adaptively manage psychological distress. It has been shown to be effective at reducing psychological distress among women who have experienced gender-based violence in informal settlements in Nairobi, Kenya. PM+ involves five 90-minute, weekly individual sessions focused on learning and practicing a stress management technique; identifying, defining, and managing problems through goal setting and review; increasing engagement in positive activities; strengthening social supports; and developing plans to stay healthy and well beyond the intervention.
Intervention outcomes will be assessed at four time points: baseline, immediately post intervention (IPI), 3-month, and 6-month follow-up.
To reduce contamination, CHVs will either carry out assessment or facilitate the intervention. Some CHVs will deliver PM+-only while others will deliver the WINGS+PM+ intervention. Project staff will meet regularly with CHVs providing PM+ only to establish the types of support and counselling they offered to participants and check that there was no contamination of the WINGS+PM+ strategies in the PM+-only arm. All intervention sessions will be audio-recorded for quality assurance.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Samantha C Winter, PhD
- Phone Number: +1 212-851-2271
- Email: scw2154@columbia.edu
Study Contact Backup
- Name: Susan S Witte, PhD
- Phone Number: +1 212-851-2394
- Email: ssw12@columbia.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Reports experiencing IPV in the past 3 months using the WHO IPV-BSS screener
- Reports feeling safe participating in the study
- Able to provide informed consent and follow study procedures
- Fluent in English and/or Swahili
- At least 18 years of age
Exclusion Criteria:
- Does not report IPV in the past 3 months,
- Does not feel safe participating in study,
- Unable to provide informed consent and/or follow study procedures,
- Cannot communicate in English or Swahili,
- Under the age of 18 years
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: WINGS+PM+
WINGS+PM+ is a safety, harm reduction, and brief psychological intervention that involves seven 90-minute weekly sessions focused on exploring types and mechanisms of IPV; building motivation to address IPV; safety planning and revision; enhancing social support to address IPV; goal setting and revision; identifying IPV-related services and needs; linkage and referral to services; self-care planning; learning and practicing a stress management technique; identifying, defining, and managing problems through goal setting and review; increasing engagement in positive activities; strengthening social supports; and developing plans to stay healthy and well beyond the intervention.
|
WINGS+PM+ is a safety, harm reduction, and brief psychological intervention combined and adapted by community members from informal settlements in Kenya (IPV survivors, health clinic staff, and CHVs) from two evidence-based interventions: Wings of Hope (WINGS) and Problem Management Plus (PM+).
This intervention was designed to be facilitated by non-specialists (e.g., CHVs).
It involves seven 90-minute weekly sessions.
The intervention is informed by social cognitive theory.
|
Active Comparator: PM+-Only
PM+: is a brief psychological intervention also designed to be facilitated by non-specialists (e.g.
CHVs) and focused on problem management and evidence-based behavioral strategies to enhance one's capacity to adaptively manage psychological distress.
It has been shown to be effective at reducing psychological distress among women who have experienced gender-based violence in informal settlements in Nairobi, Kenya.
PM+ involves five 90-minute, weekly individual sessions focused on learning and practicing a stress management technique; identifying, defining, and managing problems through goal setting and review; increasing engagement in positive activities; strengthening social supports; and developing plans to stay healthy and well beyond the intervention.
|
PM+: is a brief psychological intervention also designed to be facilitated by non-specialists (e.g.
CHVs) and focused on problem management and evidence-based behavioral strategies to enhance one's capacity to adaptively manage psychological distress.
It has been shown to be effective at reducing psychological distress among women who have experienced gender-based violence in informal settlements in Nairobi, Kenya.
PM+ involves five 90-minute, weekly individual sessions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
World Health Organization (WHO) Violence Against Women (VAW) diagnostic instrument
Time Frame: Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
A modified version of the WHO-VAW Corr 5 will be used to measure recent experience of IPV.
The WHO IPV diagnostic tool has been used in Kenya previously.
It includes four subscales measuring controlling behaviors (7 items) and sexual (3 items), physical (6 items), and emotional IPV (4 items).
Participants will be asked whether or not (0=no, 1=yes) and the number of times they experienced any of these IPV items in the prior 90 days at baseline, IPI, and the 3- and 6- month follow-up.
|
Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Receipt of violence services
Time Frame: Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Receipt of violence-related services will be measured with an item used in prior assessments of WINGS that asks, 'Have you received any services, counselling or group support for partner abuse or violence from others in the past 90 days?'
|
Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Domestic Violence Coping Self-efficacy Scale (DVCSE)
Time Frame: Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
IPV self-efficacy will be assessed using the DVCSE, a 30-item scale that measures perceived competency in managing abuse and conflict with partners.
The items are rated on a 5-point Likert scale ranging from "not at all confident" to "very confident".
|
Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Multidimensional Scale of Perceived Social Support (MSPSS)
Time Frame: Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Social Support will be measured with the 12-item MSPSS, which assesses the availability of emotional and instrumental support and advice for relationship conflict or problems with intimate partners and other issues.
Items are measured on a 7-point Likert scale ranging from very strongly disagree (1) to very strongly agree.
High scores on the scale suggest higher levels of social support.
|
Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Safety Behavior Checklist
Time Frame: Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Safety behaviors will be assessed using an updated version of a 7-item safety behavior checklist to determine present use of safety behaviors and to chart future adoption.
The adjusted total score falls within a 0-7 range of behaviors performed, with higher scores suggesting more safety behaviors.
|
Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Psychological distress (GHQ-12)
Time Frame: Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Psychological distress will be measured with the Kiswahili version of the GHQ-12, which indexes psychological distress, including anxiety and depression, in the past few weeks.
The GHQ-12 comprises 12 questions scored on a 4-point scale ranging from 0 to 3 (range 0-36; higher scores indicate more severe psychological distress).
A cutoff of 12/13 (using the 4-point continuous scoring system can be used to detect psychological morbidity, as has previously been used in Kenyan trials of the PM+ intervention.
|
Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Functioning (WHODAS 2.0)
Time Frame: Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Functional impairment will be measured using the WHODAS 2.0.
This 12-item instrument assesses difficulty in completing activities in the last 30 days (range 0-48; higher scores indicate greater impairment severity).
The WHODAS 2.0 has been used widely as a screening and outcome measure, demonstrates moderate to strong evidence of construct- and criterion-related validity, displays good sensitivity to change and has been used previously in PM+ efficacy trials in Kenya and in informal settlements in Kenya.
|
Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Short form of the Posttraumatic Stress Disorder Checklist (PCL-5)
Time Frame: Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
A four-item, short version of the Posttraumatic Stress Disorder Checklist (PCL) will be used to measure symptoms of PTSD.
The PCL was adapted and used for an efficacy trial of PM+ in Kenya.
Items are scored with a 5-point Likert ranging from 0= "not at all" to 4="extremely", with high scores suggesting symptoms of PTSD.
|
Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Personalized outcomes (PSYCHLOPS)
Time Frame: Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
The Psychological Outcome Profiles (PSYCHLOPS) scale will be used to assess change in relation to problems that are identified by the participant.
It asks respondents to nominate 2 of their main problems and to provide ratings on the magnitude of the problems and their effects on functioning and well-being in the previous week.
It is sensitive to change and is internally reliable.
PSYCHLOPS assesses the impact of interventions on problems that are not necessarily assessed by other standardized measures; thus, it can be useful in the context of informal settlements, where people can suffer a diverse range of problems.
It has also been used in an efficacy trial of PM+ in Kenya.
|
Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality control/intervention fidelity
Time Frame: Through study completion, an average of 8 months
|
Using monitoring systems from previous studies (adherence to activities and delivery quality checklists), investigators will assess intervention protocol fidelity.
Investigators will audiotape all intervention sessions and randomly select and review 15% in order to assess quality control and implementation fidelity.
Fidelity levels below 80% will trigger retraining and closer supervision.
|
Through study completion, an average of 8 months
|
Facilitator Satisfaction and ease of intervention delivery (EBPAS-36)
Time Frame: Through study completion, an average of 8 months
|
Facilitator satisfaction and ease of intervention delivery will be assessed with a shortened version of the Evidence-Based Practice Attitude Scale (EBPAS-36).
Responses are given on a 5-point Likert scale ranging from 0="not at all" to 4="to a very great extent."
With high scores indicating satisfaction.
|
Through study completion, an average of 8 months
|
Adverse events
Time Frame: Through study completion, an average of 8 months
|
Safety will be assessed through adverse event reporting by CHVs/Research Assistant (RA)/clinic staff and exit interviews with CHVs asking about negative intervention experiences.
|
Through study completion, an average of 8 months
|
Participant satisfaction with intervention
Time Frame: Through study completion, an average of 8 months
|
Participants will be asked to rate their satisfaction with the session at the end of each intervention session.
|
Through study completion, an average of 8 months
|
Number of participants in attendance at sessions
Time Frame: Through study completion, an average of 8 months
|
Attendance for each participant at each session will be tracked.
|
Through study completion, an average of 8 months
|
Retention Rate
Time Frame: Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Retention through assessment completion will be tracked and, to the extent possible, investigators will follow-up with participants who dropped out to inquire after the reasons for drop out.
|
Baseline, immediately post intervention, 3-month follow-up, 6-month follow-up
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- K01TW011775 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychological Distress
-
Utah State UniversityRecruitingPsychological Distress | Psychological Flexibility | Psychological Well-BeingUnited States
-
University of Campania "Luigi Vanvitelli"RecruitingPsychological Distress | Psychological Intervention | University StudentsItaly
-
Gunther MeinlschmidtRecruitingPsychological DistressGermany
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Recruiting
-
University of WaterlooActive, not recruitingPsychological DistressCanada
-
Dokuz Eylul UniversityActive, not recruitingPsychological DistressTurkey
-
VA Eastern Colorado Health Care SystemUniversity of Colorado, Denver; Military Suicide Research ConsortiumCompletedPsychological DistressUnited States
-
University of ZurichFreie Universität BerlinTerminatedPsychological DistressSwitzerland, Germany
-
Combat StressRoyal British LegionCompletedPsychological DistressUnited Kingdom
-
Norwegian Knowledge Centre for the Health ServicesUniversity of Oslo; University of Tromso; Norwegian Medical AssociationUnknown
Clinical Trials on WINGS+PM+
-
Columbia UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Wings Health AGUniversity Hospital, Basel, SwitzerlandRecruitingProstate Cancer | Psychosocial StressorSwitzerland
-
Chengdu Zenitar Biomedical Technology Co., LtdRecruitingStudy of Purinostat Mesylate for Injection in the Treatment of Diffuse Large B-cell Lymphoma (DLBCL)Diffuse Large B Cell Lymphoma,DLBCLChina
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Not yet recruitingHealthy | Overweight and ObesityUnited States
-
University Hospital Inselspital, BerneImaCor, Inc.Completed
-
Anhui Medical UniversityRecruitingTreatment Resistant Depression | Problem Management Plus | Event-Related PotentialsChina
-
Yale UniversityNational Institute on Drug Abuse (NIDA); US Department of Veterans Affairs; National...Completed
-
International Islamic University, IslamabadAid To Leprosy Patients (ALP), Rawalpindi-PakistanCompletedPsychological Distress | Physical Condition, Minor Psychological ComponentPakistan
-
Yale UniversityNational Institute on Drug Abuse (NIDA); US Department of Veterans Affairs; National...Active, not recruiting
-
Rigshospitalet, DenmarkRegion Capital Denmark; Region ZealandRecruitingIschemic Heart DiseaseDenmark